Selected article for: "cc NC ND International license and MERS cov"

Author: changzheng wang; Chengbin Li
Title: Preliminary study to identify severe from moderate cases of COVID-19 using NLR&RDW-SD combination parameter
  • Document date: 2020_4_14
  • ID: jecsj3xw_39
    Snippet: Of the 45 patients, 40 (89%) had fever and 27 (60%) had dry cough, 19 (42%) had fatigue, 15 (33%) had chills and 13 (28.9%) had myalgia. Fever and dry cough were still the most common symptoms in patients with COVID-19. Although there are not many cases reviewed, but the trend is similar to that reported in the literature [26, 33] . In the comparison of hematological parameters, WBC, Neu#, NLR, PLR, RDW-CV and RDW-SD in the severe group were sign.....
    Document: Of the 45 patients, 40 (89%) had fever and 27 (60%) had dry cough, 19 (42%) had fatigue, 15 (33%) had chills and 13 (28.9%) had myalgia. Fever and dry cough were still the most common symptoms in patients with COVID-19. Although there are not many cases reviewed, but the trend is similar to that reported in the literature [26, 33] . In the comparison of hematological parameters, WBC, Neu#, NLR, PLR, RDW-CV and RDW-SD in the severe group were significantly higher than that in the moderate group (P <0.05); meanwhile, Lym#, Eos#, HFC%, RBC, HGB and HCT in the severe group were significantly lower than that in the moderate group (P <0.05). Among them, WBC and Neu # are significantly higher in severe patients. It may be related to the persistent infection and prolonged hypoxia, leading to compensatory hyperplasia of the bone marrow to release more granulocytes and the results are consistent with the findings of Chen et al [27] . The significant lymphopenia in the severe group may be caused by the SARS-CoV-2 continuing to invade more lymphocytes, proliferate and cause the lymphocytes to die even to become depleted when they reach the spleen and other immune organs. The lymphopenia has been reported by many scholars [9, 11, 14, 16, [25] [26] [27] [28] . The same phenomenon was also seen in SARS-CoV and MERS-CoV infections [29] [30] . The trend of LYM # we found is consistent with the description mentioned in the Diagnosis and Treatment Guidelines (Trial Version 6) [2] . A study of . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

    Search related documents:
    Co phrase search for related documents
    • cc NC ND International license and dry cough: 1, 2, 3, 4, 5
    • cc NC ND International license and dry Fever cough: 1, 2, 3
    • cc NC ND International license and immune organ: 1
    • cc NC ND International license and International license: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • cc NC ND International license and MERS cov: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
    • cc NC ND International license and MERS cov infection: 1, 2
    • cc NC ND International license and moderate group: 1
    • common symptom and dry cough: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
    • common symptom and dry Fever cough: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • common symptom and immune organ: 1
    • common symptom and International license: 1
    • common symptom and MERS cov: 1, 2
    • common symptom and MERS cov infection: 1, 2
    • common symptom and moderate group: 1, 2
    • common symptom and patient common symptom: 1, 2, 3, 4
    • compensatory hyperplasia and moderate group: 1
    • dry cough and literature report: 1, 2, 3, 4
    • dry cough and MERS cov: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • dry cough and moderate group: 1, 2, 3, 4